We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT04451824
Previous Study | Return to List | Next Study

Examination of Circumferential Reduction

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04451824
Recruitment Status : Completed
First Posted : June 30, 2020
Last Update Posted : June 30, 2020
Information provided by (Responsible Party):
Contour Research

Brief Summary:
The rationale for the selection of Outcome Measures is the compliance with FDA regulations as pertain to medical devices with a moderate level of risk of hazard leading to harm of the patient; firstly, the safety of the device in achieving the desired effect of its intended use when operated in the intended manner; and secondly, the effectiveness of the device in achieving its desired effect of its intended use in accordance with its proposed label and labeling. The rationale for the selection of the primary outcome measure is to satisfy the question of safety and effectiveness of the use of red-light exposure to reduce the circumference of overweight patients with a statistically significant Routine Use population size. Given that the Routine Use Data Analysis is open label and therefore not blinded, there is no need for a control group nor additional cohorts for varying levels of exposure and corresponding safety and/or effectiveness.

Condition or disease Intervention/treatment Phase
Overweight or Obesity Device: CL-100 Not Applicable

Detailed Description:
In the 1960s, the concept of using light energy for a variety of health maintenance goals and overcoming a number of dermatological conditions began in earnest to receive the attention of NASA researchers as a means of providing desired clinical outcomes to astronauts while in the confines of a space capsule over long periods of time. The research was well funded and supported by the U.S. government, and confirmed the value of light emitting diode (LED) low-level light therapy (LLLT), in particular red light from the 635nm frequency, for producing a variety of healthful effects within the dermis. The ability to achieve a reduction in the dimensions of exposed liposomes using red light is intended to be confirmed by analyzing the clinical data from a minimum of one hundred patients who were exposed to the 635 nm frequency for 30 minutes by use of the subject device (Contour Light) during routine use to confirm that the device is safe and effective for its intended application. Please see the following clinical articles, appended in section 10.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 118 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Intervention Model Description: Routine use of device
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Contour Research CL-100 Examination of Circumferential Reduction: A Review of Data Collected From Routine Use of the Device
Actual Study Start Date : September 1, 2018
Actual Primary Completion Date : November 30, 2018
Actual Study Completion Date : December 31, 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Health Checkup

Arm Intervention/treatment
Experimental: Intervention with Routine Use of Red Light
Routine Use of red light (635nm) for 30 minutes on patients is to be observed in relation to its effect(s) in achieving circumferential reduction of the thighs, hips and waist of the patient, and a contour reduction of any protrusion of fat.
Device: CL-100
Red Light LED device for circumferential reduction

Primary Outcome Measures :
  1. Examination of Circumferential Reduction - Primary Objective [ Time Frame: <1 hour ]
    To confirm the proper use of the device induces a change in the circumference of the patients thighs, hips and waist, when exposed to the red light (635nm)

Secondary Outcome Measures :
  1. Examination of Circumferential Reduction - Secondary Objective [ Time Frame: <1 hour ]
    To achieve a contour change, specifically a lessening of the protrusion of body fat, when exposed to the red light (635nm)

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Males and Females ages 18 and above
  • Generally good health

Exclusion Criteria:

  • Pregnancy
  • Active cancer within the past year
  • Pacemaker
  • Diminished ability to void waste (liver and/or kidney function impairment)
  • Photosensitivity (generally and/or from medication)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04451824

Layout table for location information
United States, California
Gibson Clinic
Vista, California, United States, 92083
United States, Georgia
Barone Clinic
Savannah, Georgia, United States, 31410
United States, Washington
Love Clinic
Kirkland, Washington, United States, 98034
Sponsors and Collaborators
Contour Research
Layout table for investigator information
Principal Investigator: Doug Dreier, BS Contour Research, LLC
Layout table for additonal information
Responsible Party: Contour Research
ClinicalTrials.gov Identifier: NCT04451824    
Other Study ID Numbers: CL100 CR RetrX1
First Posted: June 30, 2020    Key Record Dates
Last Update Posted: June 30, 2020
Last Verified: June 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: There is no plan to share the individual participant data with other researchers.

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: Yes
Device Product Not Approved or Cleared by U.S. FDA: Yes
Product Manufactured in and Exported from the U.S.: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Body Weight